J Family Med Prim Care. 2020 Apr 30;9(4):1834-1840. doi: 10.4103/jfmpc.jfmpc_1037_19. eCollection 2020 Apr.
PMID:32670927
Acute lymphoblastic leukemia/lymphoma of the oral and maxillofacial region.
Sánchez-Romero C, Pontes HAR, Pontes FSC, Rocha AC, Carlos R, Rendón JC, de Almeida OP, Fonseca FP.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Aug;126(2):152-164. doi: 10.1016/j.oooo.2018.01.010. Epub 2018 Jan 31.
PMID:29678441
Mantle cell lymphoma involving the oral and maxillofacial region: a study of 20 cases.
Carvalho MVR, Rodrigues-Fernandes CI, de Cáceres CVBL, Mesquita RA, Martins MD, Román Tager EMJ, Carlos R, Pires FR, Robinson L, van Heerden WFP, Valente VB, Xavier-Júnior JCC, Bernabé DG, Pontes HAR, Soares CD, da Costa MHM, Vargas PA, Fonseca FP.
Clinicopathological and genetic characteristics of diffuse large B-cell lymphoma of the oropharyngeal and maxillofacial region.
Xia S, Yue J, Chen X, Hu Y, Guo F, Zhang J.
Oral Dis. 2021 Apr;27(3):448-456. doi: 10.1111/odi.13578. Epub 2020 Aug 20.
PMID:32731312
Management of Non-Hodgkin's Lymphoma in Maxillofacial Region with Chemotherapy.
Moin A, Shetty AD.
Ann Maxillofac Surg. 2017 Jul-Dec;7(2):312-315. doi: 10.4103/ams.ams_85_17.
PMID:29264306
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, Zhang L, Deng X, Gong Z, Zhang S, Yan Q, He Y, Li X, Shi L, Guo C, Wang F, Li Z, Zhou M, Xiang B, Li Y, Xiong W, Zeng Z.
Nat Commun. 2022 Feb 14;13(1):866. doi: 10.1038/s41467-022-28479-2.
PMID:35165282
Mature T/NK-Cell lymphomas of the oral and maxillofacial region: A multi-institutional collaborative study.
de Arruda JAA, Abrantes TC, Cunha JLS, Roza ALOC, Agostini M, Abrahão AC, Canedo NHS, Ramos DD, Milito CB, Pontes FSC, Pontes HAR, Barra MB, Zanella VG, Martins MAT, Martins MD, Israel MS, Freire NA, Barreto MEZ, Sánchez-Romero C, Carlos R, Abreu LG, Vargas PA, de Almeida OP, Fonseca FP, Romañach MJ, Mesquita RA, de Andrade BAB.